share_log
Breakings ·  Jun 3 20:00
Indaptus Therapeutics Announces New Positive Data From Ongoing Phase 1 Trial of Decoy20
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment